The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure

Clinical Science

Volumn 126, Issue 10, 2014, Pages 695-706

  Zucker, Irving H ^a   Xiao, Liang ^a   Haack, Karla K V ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Angiotensin II type 2 receptor (AT2R); Angiotensin (1 7); Angiotensin converting enzyme; angiotensin converting enzyme 2; heart failure; Renin angiotensin system

Indexed keywords

ANIMALS; CHRONIC DISEASE; EXERCISE; HEART FAILURE; HUMANS; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 84893924089     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130294     Document Type: Review

References (103)

1. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S. et al. (2011) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2-e220
2. Dzau, V. J., Colucci, W. S., Hollenberg, N. K. and Williams, G. H. (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63, 645-651
3. Francis, G. S. (1989) The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am. Heart J. 118, 642-648
4. Holtz, J. (1993) Pathophysiology of heart failure and the renin-angiotensin-system. Basic Res. Cardiol. 88, 183-201
5. Bristow, M. R., Minobe, W., Rasmussen, R., Larrabee, P., Skerl, L., Klein, J. W., Anderson, F. L., Murray, J., Mestroni, L. and Karwande, S. V. (1992) β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest. 89, 803-815 702 C
6. 1-receptor down-regulation in heart failure. Circ. Res. 59, 297-309
7. Freeman, K., Lerman, I., Kranias, E. G., Bohlmeyer, T., Bristow, M. R., Lefkowitz, R. J., Iaccarino, G., Koch, W. J. and Leinwand, L. A. (2001) Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest. 107, 967-974
8. Ljungman, S., Laragh, J. H. and Cody, R. J. (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39, 10-21
9. Sobotka, P. A., Krum, H., Bohm, M., Francis, D. P. and Schlaich, M. P. (2012) The role of renal denervation in the treatment of heart failure. Curr. Cardiol. Rep. 14, 285-292
10. Felder, R. B., Francis, J., Zhang, Z. H., Wei, S. G., Weiss, R. M. and Johnson, A. K. (2003) Heart failure and the brain: new perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R259-R276
11. Francis, J., Wei, S. G., Weiss, R. M. and Felder, R. B. (2004) Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am. J. Physiol. Heart Circ. Physiol. 287, H2138-H2146
12. Hegarty, A. A., Hayward, L. F. and Felder, R. B. (1996) Influence of circulating angiotensin II and vasopressin on neurons of the nucleus of the solitary tract. Am. J. Physiol. Regul. Integr. Comp. Physiol. 270, R675-R681
13. Huang, B. S. and Leenen, F. H. (2009) The brain renin- angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr. Heart Fail. Rep. 6, 81-88
14. Zucker, I. H., Schultz, H. D., Li, Y. F., Wang, Y., Wang, W. and Patel, K. P. (2004) The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog. Biophys. Mol. Biol. 84, 217-232
15. Bains, J. S., Potyok, A. and Ferguson, A. V. (1992) Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res. 599, 223-229
16. 1 receptors in the paraventricular nucleus mediate the hyperthermia-induced reflex reduction of renal blood flow in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R479-R485
17. 1 receptor upregulation and NAD(P)H oxidase in RVLM. Am. J. Physiol. Heart Circ. Physiol. 288, H2271-H2279
18. Gao, L., Wang, W. Z., Wang, W. and Zucker, I. H. (2008) Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 52, 708-714
19. 1 receptors in the central control of sympathetic vasomotor function. Clin. Exp. Pharmacol. Physiol. 23, S93-S98
20. 1 receptors support blood pressure in hypertensive rats. Hypertension 40, 552-559
21. 1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 298, H1546-H1555
22. McKinley, M. J., Albiston, A. L., Allen, A. M., Mathai, M. L., May, C. N., McAllen, R. M., Oldfield, B. J., Mendelsohn, F. A. and Chai, S. Y. (2003) The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35, 901-918
23. Patel, K. P., Mayhan, W. G., Bidasee, K. R. and Zheng, H. (2011) Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R311-R320
24. Wang, G., Milner, T. A., Speth, R. C., Gore, A. C., Wu, D., Iadecola, C. and Pierce, J. P. (2008) Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1149-R1157
25. Zhu, G. Q., Gao, L., Patel, K. P., Zucker, I. H. and Wang, W. (2004) Ang II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl. Physiol. 97, 1746-1754
26. Liu, J. L. and Zucker, I. H. (1999) Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ. Res. 84, 417-423
27. Zucker, I. H., Wang, W., Pliquett, R. U., Liu, J.L. and Patel, K. P. (2001) The regulation of sympathetic outflow in heart failure. In Neuro-Cardiovascular Regulation (Chapleau, M. W. and Abboud, F. M., eds), pp. 431-443, New York Academy of Sciences, New York
28. Gao, L., Wang, W., Li, Y. L., Schultz, H. D., Liu, D., Cornish, K. G. and Zucker, I. H. (2004) Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 95, 937-944
29. 1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ. Res. 103, 186-193
30. Guggilam, A., Cardinale, J. P., Mariappan, N., Sriramula, S., Haque, M. and Francis, J. (2011) Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide. Basic Res. Cardiol. 106, 273-286
31. Huang, B. S., Zheng, H., Tan, J., Patel, K. P. and Leenen, F. H. (2011) Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone. Exp. Physiol. 96, 1028-1038
32. 1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 287, H1828-H1835
33. Wang, Y., Seto, S. W. and Golledge, J. (2012) Angiotensin II, sympathetic nerve activity and chronic heart failure. Heart Fail. Rev., doi:10.1007/s10741-012-9368-1
34. Yoshimura, R., Sato, T., Kawada, T., Shishido, T., Inagaki, M., Miyano, H., Nakahara, T., Miyashita, H., Takaki, H., Tatewaki, T. et al. (2000) Increased brain angiotensin receptor in rats with chronic high-output heart failure. J. Card. Fail. 6, 66-72
35. DiBona, G. F., Jones, S. Y. and Brooks, V. L. (1995) Ang II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 269, R1189-R1196
36. Zhang, W., Huang, B. S. and Leenen, F. H. (1999) Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 276, H1608-H1615
37. Wang, H., Huang, B. S., Ganten, D. and Leenen, F. H. (2004) Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ. Res. 94, 843
38. Liu, D., Gao, L., Roy, S. K., Cornish, K. G. and Zucker, I. H. (2006) Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ. Res. 99, 1004-1011
39. Liu, J. L., Irvine, S., Reid, I. A., Patel, K. P. and Zucker, I. H. (2000) Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: a role for angiotensin II. Circulation 102, 1854-1862
40. Mitra, A. K. and Zucker, I. H. (2011) Convergence of p38MAPK pathway and nuclear signals involving NFκB/CREB following Ang II stimulation in neurons. FASEB J. 25, 843.16
41. Kang, Y. M., Ma, Y., Zheng, J. P., Elks, C., Sriramula, S., Yang, Z. M. and Francis, J. (2009) Brain nuclear factor-κB activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc. Res. 82, 503-512
42. Elks, C. M., Mariappan, N., Haque, M., Guggilam, A., Majid, D. S. and Francis, J. (2009) Chronic NF-κB blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am. J. Physiol. Renal Physiol. 296, F298-F305
43. Sumners, C. and Gelband, C. H. (1998) Neuronal ion channel signalling pathways: modulation by angiotensin II. Cell. Signal. 10, 303-311
44. 2+ currents: intracellular mechanisms. Am. J. Physiol. Cell Physiol. 271, C154-C163
45. 2+ currents in cultured neurons by an angiotensin II type 1a receptor peptide. Am. J. Physiol. Cell Physiol. 273, C1040-C1048
46. Gao, L., Li, Y., Schultz, H. D., Wang, W. Z., Wang, W., Finch, M., Smith, L. M. and Zucker, I. H. (2010) Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 298, H945-H955
47. Jin, H., Hadri, L., Palomeque, J., Morel, C., Karakikes, I., Kaprielian, R., Hajjar, R. and Lebeche, D. (2010) KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. J. Mol. Cell. Cardiol. 48, 1169-1179
48. Li, X., Tang, K., Xie, B., Li, S. and Rozanski, G. J. (2008) Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system. Am. J. Physiol. Heart Circ. Physiol. 295, H416-H424
49. Ozgen, N., Lu, Z., Boink, G. J., Lau, D. H., Shlapakova, I. N., Bobkov, Y., Danilo, Jr, P., Cohen, I. S. and Rosen, M. R. (2012) Microtubules and angiotensin II receptors contribute to modulation of repolarization induced by ventricular pacing. Heart Rhythm 9, 1865-1872
50. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
51. Ferrario, C. M., Santos, R. A., Brosnihan, K. B., Block, C. H., Schiavone, M. T., Khosla, M. C. and Greene, L. J. (1988) A hypothesis regarding the function of angiotensin peptides in the brain. Clin. Exp. Hypertens. A, 10 (Suppl. 1), 107-121
52. Ferreira, A. J., Murca, T. M., Fraga-Silva, R. A., Castro, C. H., Raizada, M. K. and Santos, R. A. (2012) New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis. Int. J. Hypertens. 2012, 147825
53. Feng, Y., Xia, H., Cai, Y., Halabi, C. M., Becker, L. K., Santos, R. A., Speth, R. C., Sigmund, C. D. and Lazartigues, E. (2009) Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ. Res. 106, 373-382
54. Xia, H., Feng, Y., Obr, T. D., Hickman, P. J. and Lazartigues, E. (2009) Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension 53, 210-216
55. Shenoy, V., Qi, Y., Katovich, M. J. and Raizada, M. K. (2011) ACE2, a promising therapeutic target for pulmonary hypertension. Curr. Opin. Pharmacol. 11, 150-155
56. Zimmerman, D. and Burns, K. D. (2012) Angiotensin-(1-7) in kidney disease: a review of the controversies. Clin. Sci. 123, 333-346
57. Qian, Y. R., Guo, Y., Wan, H. Y., Fan, L., Feng, Y., Ni, L., Xiang, Y. and Li, Q. Y. (2013) Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition. Oncol. Rep. 29, 2408-2414
58. Gallagher, P. E. and Tallant, E. A. (2004) Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25, 2045-2052
59. Krishnan, B., Smith, T. L., Dubey, P., Zapadka, M. E., Torti, F. M., Willingham, M. C., Tallant, E. A. and Gallagher, P. E. (2013) Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate 73, 71-82
60. Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L. and Lazartigues, E. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R373-R381
61. Hamming, I., Timens, W., Bulthuis, M. L., Lely, A. T., Navis, G. and van Goor, H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631-637
62. Xiao, L., Gao, L., Lazartigues, E. and Zucker, I. H. (2011) Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure. Hypertension 58, 1057-1065
63. Zheng, H., Liu, X. and Patel, K. P. (2011) Angiotensin-converting enzyme 2 overexpression improves central nitric oxidemediated sympathetic outflow in chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 301, H2402-H2412
64. 1 receptors in neurons. Am. J. Physiol. Cell Physiol. 302, C1162-C1173
65. Potts, P. D., Horiuchi, J., Coleman, M. J. and Dampney, R. A. (2000) The cardiovascular effects of angiotensin-(1-7) in the rostral and caudal ventrolateral medulla of the rabbit. Brain Res. 877, 58-64
66. Silva, A. Q., Santos, R. A. and Fontes, M. A. (2005) Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 46, 341-348
67. Xia, H., Suda, S., Bindom, S., Feng, Y., Gurley, S. B., Seth, D., Navar, L. G. and Lazartigues, E. (2011) ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS ONE 6, e22682
68. Diz, D. I., Garcia-Espinosa, M. A., Gallagher, P. E., Ganten, D., Ferrario, C. M. and Averill, D. B. (2008) Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats. J. Cardiovasc. Pharmacol. 51, 542-548
69. Kar, S., Gao, L., Belatti, D. A., Curry, P. L. and Zucker, I. H. (2011) Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 58, 627-634
70. Pina, I. L., Apstein, C. S., Balady, G. J., Belardinelli, R., Chaitman, B. R., Duscha, B. D., Fletcher, B. J., Fleg, J. L., Myers, J. N. and Sullivan, M. J. (2003) Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107, 1210-1225
71. Belardinelli, R., Georgiou, D., Ginzton, L., Cianci, G. and Purcaro, A. (1998) Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 97, 553-561
72. Belardinelli, R., Georgiou, D., Cianci, G. and Purcaro, A. (1999) Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99, 1173-1182
73. Georgiou, D., Chen, Y., Appadoo, S., Belardinelli, R., Greene, R., Parides, M. K. and Glied, S. (2001) Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure. Am. J. Cardiol. 87, 984-988
74. Belardinelli, R., Paolini, I., Cianci, G., Piva, R., Georgiou, D. and Purcaro, A. (2001) Exercise training intervention after coronary angioplasty: the ETICA trial. J. Am. Coll. Cardiol. 37, 1891-1900
75. Kitzman, D. W., Brubaker, P. H., Morgan, T. M., Stewart, K. P. and Little, W. C. (2010) Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ. Heart Fail. 3, 659-667
76. Brubaker, P. H., Moore, J. B., Stewart, K. P., Wesley, D. J. and Kitzman, D. W. (2009) Endurance exercise training in older patients with heart failure: results from a randomized, controlled, single-blind trial. J. Am. Geriatr. Soc. 57, 1982-1989
77. Mousa, T. M., Liu, D., Cornish, K. G. and Zucker, I. H. (2008) Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure. J. Appl. Physiol. 104, 616-624
78. Liu, J. L., Kulakofsky, J. and Zucker, I. H. (2002) Exercise training enhances baroreflex control of heart rate by a vagal mechanism in rabbits with heart failure. J. Appl. Physiol. 92, 2403-2408
79. 1R and GRK5 expression following exercise training in heart failure. Hypertension 60, 354-361
80. Roveda, F., Middlekauff, H. R., Rondon, M. U., Reis, S. F., Souza, M., Nastari, L., Barretto, A. C., Krieger, E. M. and Negrao, C. E. (2003) The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J. Am. Coll. Cardiol. 42, 854-860
81. Antunes-Correa, L. M., Melo, R. C., Nobre, T. S., Ueno, L. M., Franco, F. G., Braga, A. M., Rondon, M. U., Brum, P. C., Barretto, A. C., Middlekauff, H. R. and Negrao, C. E. (2010) Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure. Eur. J. Heart Fail. 12, 58-65
82. de Mello Franco, F. G., Santos, A. C., Rondon, M. U., Trombetta, I. C., Strunz, C., Braga, A. M., Middlekauff, H., Negrao, C. E. and Pereira Barretto, A. C. (2006) Effects of home-based exercise training on neurovascular control in patients with heart failure. Eur. J. Heart Fail. 8, 851-855
83. Fraga, R., Franco, F. G., Roveda, F., de Matos, L. N., Braga, A. M., Rondon, M. U., Rotta, D. R., Brum, P. C., Barretto, A. C., Middlekauff, H. R. and Negrao, C. E. (2007) Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur. J. Heart Fail. 9, 630-636
84. Zheng, H., Sharma, N. M., Liu, X. and Patel, K. P. (2012) Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R387-R394
85. Bertagnolli, M., Schenkel, P. C., Campos, C., Mostarda, C. T., Casarini, D. E., Bello-Klein, A., Irigoyen, M. C. and Rigatto, K. (2008) Exercise training reduces sympathetic modulation on cardiovascular system and cardiac oxidative stress in spontaneously hypertensive rats. Am. J. Hypertens. 21, 1188-1193
86. Gao, L., Wang, W., Liu, D. and Zucker, I. H. (2007) Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115, 3095-3102
87. Kishi, T., Hirooka, Y., Katsuki, M., Ogawa, K., Shinohara, K., Isegawa, K. and Sunagawa, K. (2012) Exercise training causes sympathoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive rats. Clin. Exp. Hypertens. 34, 278-283
88. Wang, Y. and Golledge, J. (2013) Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Curr. Neurovasc. Res. 10, 81-89
89. Coats, A. J., Adamopoulos, S., Radaelli, A., McCance, A., Meyer, T. E., Bernardi, L., Solda, P. L., Davey, P., Ormerod, O. and Forfar, C. (1992) Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85, 2119-2131
90. Kar, S., Gao, L. and Zucker, I. H. (2010) Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J. Appl. Physiol. 108, 923-932
91. Evangelista, F. S., Brum, P. C. and Krieger, J. E. (2003) Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz. J. Med. Biol. Res. 36, 1751-1759
92. Fernandes, T., Hashimoto, N. Y., Magalhaes, F. C., Fernandes, F. B., Casarini, D. E., Carmona, A. K., Krieger, J. E., Phillips, M. I. and Oliveira, E. M. (2011) Aerobic exercise training-induced left ventricular hypertrophy involves regulatory microRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension 58, 182-189
93. Yang, R. F., Yin, J. X., Li, Y. L., Zimmerman, M. C. and Schultz, H. D. (2011) Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am. J. Physiol. Cell Physiol. 300, C58-C64
94. Xiao, L., Haack, K. K. and Zucker, I. H. (2013) Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogenactivated protein kinase and extracellular signal-regulated kinase 1/2 signaling. Am. J. Physiol. Cell Physiol. 304, C1073-C1079
95. Burrell, L. M., Burchill, L., Dean, R. G., Griggs, K., Patel, S. K. and Velkoska, E. (2012) Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Exp. Physiol. 97, 477-485
96. Sriramula, S., Cardinale, J. P. and Francis, J. (2013) Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS ONE 8, e63847
97. Wakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., Makino, Y., Kato, N., Koni, I. and Miyamori, I. (2007) Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 148, 2453-2457
98. Zhang, R., Wu, Y., Zhao, M., Liu, C., Zhou, L., Shen, S., Liao, S., Yang, K., Li, Q. and Wan, H. (2009) Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L631-L640
99. 1 receptor: novel insights into mechanisms and pathophysiology. Clin. Sci. 112, 417-428
100. Oppermann, M., Freedman, N. J., Alexander, R. W. and Lefkowitz, R. J. (1996) Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J. Biol. Chem. 271, 13266-13272
101. Kim, J., Ahn, S., Ren, X. R., Whalen, E. J., Reiter, E., Wei, H. and Lefkowitz, R. J. (2005) Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling. Proc. Natl. Acad. Sci. U.S.A.[102,] 1442-1447
102. Grobe, J. L., Xu, D. and Sigmund, C. D. (2008) An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology 23, 187-193
103. Mueller, P. J. (2007) Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin. Exp. Pharmacol. Physiol. 34, 377-384